GfV 2021

09:00–09:15		Welcome note
09:15–10:50		Plenary session 1 Viral evolution and function
11:00–12:30		Workshop 1 Adaptive immunity
12:50–14:20		BioNTech The mRNA platforms against mutating SARS-CoV-2
14:35–17:05		Plenary session 2 SARS-CoV-2 – Vaccines and neutralising abs
17:20–18:05		Poster session 1 Adaptive immunity
18:05–18:50		Poster session 1 Innate immunity
19:00–20:30		Workshop 4 Innate immunity

08:00–09:30		Workshop 7 Intrinsic antiviral defenses
09:45–11:00		Plenary session 3 New emerging viruses – Pathomechanisms and replication
12:15–12:45		LI-COR Biosciences GmbH Reliable Westerns are going viral – About In-Cell WesternsTM and faster virus characterisation
12:45–13:15		AID Autoimmun Diagnostika GmbH Did we bark up the wrong tree for too long? Challenges for immunomonitoring of emerging diseases as a sum of all parts to result in a whole
13:30–15:00		Workshop 10 Clinical virology I
15:15–16:00		Poster session 2 Clinical virology I
16:00–16:45		Poster session 2 Intrinsic antiviral defenses
17:00–18:15		Plenary session 4 Immune Response to SARS-CoV-2
18:30–19:30		GfV General assembly

08:30–10:00		Workshop 13 Clinical virology II
10:15–11:45		Workshop 16 Viral replication I
11:50–12:05		BAG Diagnostics GmbH Potential of the ViroQ® real-time PCR kits in context of the pandemic of SARS-CoV-2
12:15–13:15		Takara Bio Europe SAS Detect, Decipher and Decide! Takara Bio’s Tools for Optimal Viral Surveillance.
13:30–14:15		Poster session 3 Clinical virology II
14:15–15:00		Poster session 3 Viral replication I
15:15–16:45		Plenary session 5 Systems approaches in virology and drug discovery
17:00–18:30		Loeffler-Frosch award and lectures
18:30–18:45		Farewell
19:30–21:00		Panel discussion Public panel discussion